http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1297817-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5135e1534b07d32fbfe49746aad3ca3c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-864
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-948
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-809
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-16
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
filingDate 1988-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4465fd5a8397c6d0da06077951ad2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35fa3f09d7ef861910bf6c85f43bfdef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2e0a9293b3b542df0b5d0a10c0d41cb
publicationDate 1992-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1297817-C
titleOfInvention Monoclonal antibody specific to a common determinant site of neutrophilsand eosinophils
abstract ABSTRACT OF THE DISCLOSURE A hybrid cell line capable of producing monoclonal antibodies uniquely specific to human neutrophils and eosinophils and exhibiting no specificity for lymphocytes, basophils and monocytes. Further there is no reactivity with acute leukemia cells. One of the partners in the hybridoma fu-sion of a mouse spleen cell developed from using human granulocytes as the immunization agent. The monoclonal antibody further is capable of being used to enumerate and isolate neutrophils in normal peripheral blood and possibly in blood of patients with acute leukemia.
priorityDate 1987-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID105372315
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP80025
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID76113
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A452E9Y6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA5JUY8
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID8060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID8060
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4025
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8R481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420473686
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22079

Total number of triples: 38.